Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04275830 · ClinicalTrials.gov registry record · NA
The Effects of Heart Rate Variability Biofeedback Training on Hematopoietic Cell Transplantation Patients
A NA study, sponsored by Arizona State University.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT04275830 is a NA study that has completed, run by Arizona State University. The registered enrollment target is 18 participants.
The verdict
NCT04275830, a NA study, has completed, sponsored by Arizona State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
Patients undergoing hematopoietic stem cell transplantation (HCT) often continue to experience anxiety, depression, isolation, and other psychosocial distress due to the severe nature of the transplant experience. Storytelling interventions that provide an opportunity for emotional disclosure have shown preliminary efficacy to alleviate psychosocial distress and improve emotion regulation during health challenges. Not only are these changes observed in response to such interventions, but they can also be directly strengthened with HRV biofeedback (HRVB) training, a device-driven breath pacing practice that uses colored light signals to provide feedback to increase vagal tone and improve emotional responses and sleep quality by regulating negative affect and stress. This randomized controlled trial will explore the effects of HRV biofeedback (HRVB) training combined with a digital storytelling intervention and changes in psychosocial distress with a modified waitlist control in a population of Hematopoietic cell transplantation (HCT) patients.
Interventions
- BEHAVIORAL Heart rate variability biofeedback
- BEHAVIORAL Baseline Surveys
- BEHAVIORAL Heart rate variability waitlist and Digital storytelling Control intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2020-02-04 |
| Est. Completion | 2022-02-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04275830
The ClinicalTrials.gov registry entry for NCT04275830 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Arizona State University, which has 187 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Heart rate variability biofeedback is the first listed.
NCT04275830 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04275830 about?
NCT04275830 is a clinical study titled "The Effects of Heart Rate Variability Biofeedback Training on Hematopoietic Cell Transplantation Patients". Patients undergoing hematopoietic stem cell transplantation (HCT) often continue to experience anxiety, depression, isolation, and other psychosocial distress due to the severe nature of the transplant experience. Storytelling interventions that provide an opportunity for emotional disclosure have s...
What is the current status of trial NCT04275830?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2020-02-04. Estimated completion is 2022-02-04.
What interventions are being tested in trial NCT04275830?
The interventions under investigation include: Heart rate variability biofeedback (BEHAVIORAL), Baseline Surveys (BEHAVIORAL), Heart rate variability waitlist and Digital storytelling Control intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT04275830?
This trial is sponsored by Arizona State University, which has 187 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.